Figure 1. Patient 3. (A, B). In August 2007 CT scan evaluation showing a recurrence in the liver (A) and in the peritoneum (B). (C, D). A complete radiological response (mRECIST criteria) was observed in November 2007 after 3 months of sorafenib. (E, F). In October 2012, the patient was still alive without any lesion on the CT scan, 54 months after cessation of sorafenib.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
